<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="anthelminthic/PMC7767343/results/search/disease/results.xml">
  <result pre="of MNPs described to date, such as MarinLit (http://pubs.rsc.org/marinlit/). In" exact="cancer" post="research, for example, NPs are considered very relevant as"/>
  <result pre="vivo in murine models (and others), as well as in" exact="cancer" post="clinical trials [39,42,43]. In fact, marine organisms are still"/>
  <result pre="that cytotoxic, anticancer, and antitumoral compounds are strongly needed, since" exact="cancer" post="remains one of the deadliest diseases worldwide [42]. In"/>
  <result pre="deadliest diseases worldwide [42]. In 2018, about 18 million new" exact="cancer" post="cases were reported globally, producing around 10 million deaths"/>
  <result pre="Many natural compounds present cytotoxic effects against macromolecules expressed by" exact="cancer" post="cells, such as in oncogenic signal transduction pathways, and"/>
  <result pre="modulates the Bcl-2 and p53 oncoproteins in human diffuse large-cell" exact="lymphoma" post="WSU-DLCL2, inducing a decrease in the expression of Bcl-2"/>
  <result pre="well as inducing ubiquitination and proteasome degradation of Bcl-2 in" exact="lymphoblastic leukemia," post="allowing for the growth of progenitor cells from bone"/>
  <result pre="analogues which were tested for growth inhibitory activity against some" exact="cancer" post="cell lines in vitro [506,507,508]. Actinofide (205) and some"/>
  <result pre="(205) and some of its analogues were tested against six" exact="cancer" post="cell lines: two human carcinoma cancer cell lines (MCF-7"/>
  <result pre="were tested against six cancer cell lines: two human carcinoma" exact="cancer" post="cell lines (MCF-7 (breast) and A549 (non–small-cell lung cancer,"/>
  <result pre="human carcinoma cancer cell lines (MCF-7 (breast) and A549 (non–small-cell" exact="lung cancer," post="NSCLC)) of epithelial origin, two human cancer cell lines"/>
  <result pre="A549 (non–small-cell lung cancer, NSCLC)) of epithelial origin, two human" exact="cancer" post="cell lines from glial origin (Hs683 oligodendroglioma and U373"/>
  <result pre="origin, two human cancer cell lines from glial origin (Hs683" exact="oligodendroglioma" post="and U373 glioblastoma of astrocytic origin), and two melanoma"/>
  <result pre="and 11-epivaldiviolide (208), some of them displaying cytotoxicity against murine" exact="leukemia" post="P388 cell lines [87]. In particular, the IC50 values"/>
  <result pre="which show in vitro growth inhibitory activity against four human" exact="cancer" post="cell lines [111]. In particular, this activity was tested"/>
  <result pre="HeLa (cervical), MCF-7 (breast), KB (oral cavity), and HT-29 (colon)" exact="cancer" post="cell lines with IC50 values between 0.05 and 10"/>
  <result pre="values of ~1 μM for both, and against mouse L1210" exact="leukemia" post="cells, with IC50 values of ~2 and ~0.3 μM,"/>
  <result pre="the organization of cell microfilaments, and inhibit the proliferation of" exact="cancer" post="cells due to their strong actin binding properties [153,164,515,516,517]."/>
  <result pre="and B (37) display antimigratory activity against highly metastatic human" exact="prostate cancer" post="PC-3M-CT+ cells and murine brain-metastatic melanoma B16B15b cells [515,518]."/>
  <result pre="B (37) display antimigratory activity against highly metastatic human prostate" exact="cancer" post="PC-3M-CT+ cells and murine brain-metastatic melanoma B16B15b cells [515,518]."/>
  <result pre="values of ~0.5 μM against murine P388 leukemia, human HT-29" exact="colon cancer," post="and human A549 NSCLC, with more than a fivefold"/>
  <result pre="vitro growth inhibitory effects against A549 NSCLC than to P388" exact="leukemia" post="[519]. Latrunculin A (38), coded NSC613011 on the NCI"/>
  <result pre="an IC50 mean value of ~0.7 μM in the 60" exact="cancer" post="cell line panel, with a more than twofold log"/>
  <result pre="magnitude difference between the most sensitive and the most resistant" exact="cancer" post="cell lines, being as active against MDR NCI/ADR-RES as"/>
  <result pre="MDR phenotype [47]. Finally, latrunculin A (38) induces apoptosis in" exact="cancer" post="cells via activation of the caspase-3/caspase-7 pathway and displays"/>
  <result pre="in peritoneal dissemination models of MKN45 and NUGC-4 human gastric" exact="cancer" post="in mice [455]. In vivo anticancer assays using A549"/>
  <result pre="agents [142,523,524]. Laulimalide (39) inhibits growth in more than ten" exact="cancer" post="cell lines at low nanomolar concentrations, while isolaulimalide (40)"/>
  <result pre="molecules [527]. Moreover, laulimalide (39) has an effect in P-gp-overexpressing" exact="cancer" post="cells and against cell lines resistant to paclitaxel and"/>
  <result pre="paclitaxel and epothilones [525,528]. Further studies have shown that in" exact="ovarian cancer" post="cells, the increased expression of βII- and βIII tubulin"/>
  <result pre="and epothilones [525,528]. Further studies have shown that in ovarian" exact="cancer" post="cells, the increased expression of βII- and βIII tubulin"/>
  <result pre="of laulimalide (39) in two xenograft models, the human MDA-MB-435" exact="breast cancer" post="and the human HT-1080 fibrosarcoma models, describing little tumor"/>
  <result pre="laulimalide (39) in two xenograft models, the human MDA-MB-435 breast" exact="cancer" post="and the human HT-1080 fibrosarcoma models, describing little tumor"/>
  <result pre="models, the human MDA-MB-435 breast cancer and the human HT-1080" exact="fibrosarcoma" post="models, describing little tumor growth inhibition accompanied by a"/>
  <result pre="aspersa) and other scalarane terpenoids are cytotoxic against murine L1210" exact="leukemia" post="and human epidermoid carcinoma KB cell lines [156]. Particularly,"/>
  <result pre="Epoxygoniolide-1 (219) shows moderate cytotoxicity to NCIH-460, SW60, and HepG2" exact="cancer" post="cells [532]. G. (Chromodoris) sinensis from China presents aplyroseol-2"/>
  <result pre="together with the ring-closed acetal, both bioactive against P388 mouse" exact="leukemia" post="cells [161,186]. G. reticulatus contains spongian-16-one (221), aplytandiene-3 (222),"/>
  <result pre="(221) [154]. All of these compounds are active against murine" exact="lymphoma" post="L1210 and human epidermoid carcinoma KB cells at IC50"/>
  <result pre="[180,381,383,384,385,386,519,535,538,539,540]. In particular, spongiadiol (35) is active against P388 murine" exact="leukemia" post="cells at an IC50 of 0.5 μg/mL. Other species,"/>
  <result pre="three-dimensional (3D) cell culture model, using spheroids of the MCF-7" exact="breast cancer" post="cell [541,542]. Hypselodoris infucata from Bali presents (–)-furodysinin (48),"/>
  <result pre="(3D) cell culture model, using spheroids of the MCF-7 breast" exact="cancer" post="cell [541,542]. Hypselodoris infucata from Bali presents (–)-furodysinin (48),"/>
  <result pre="Both compounds are reported to display activity against murine L1210" exact="leukemia" post="cells, with IC50 values of ~10 and ~30 nM,"/>
  <result pre="(62) presents growth inhibitory effects in vitro against human MCF-7" exact="breast cancer" post="cells (IC50 ~0.5 μM), ten times higher than for"/>
  <result pre="presents growth inhibitory effects in vitro against human MCF-7 breast" exact="cancer" post="cells (IC50 ~0.5 μM), ten times higher than for"/>
  <result pre="stronger bioselectivity, with IC50 values of 0.02 μM against MCF-7" exact="cancer" post="cells and &amp;gt;2 μM for human fibroblasts [548]. Kabiramides"/>
  <result pre="with IC50 values of ~30 nM, against the murine L1210" exact="leukemia" post="cell line [220]. On the other hand, dihydrohalichondramide (63)"/>
  <result pre="(63) and 33-methylhalichondramide (242) inhibit growth in the murine L1210" exact="leukemia" post="cell line with IC50 values of ~40 and ~60"/>
  <result pre="low concentrations, with an IC50 of 12.5 ng/mL against some" exact="cancer" post="cell lines, such as P388, A549, HT29, and MEL28,"/>
  <result pre="(189) is in phase II clinical studies for endometrial and" exact="cervical cancer," post="as well as solid human tumors and hematological diseases"/>
  <result pre="low nanomolar ranges against human colon (HCT-116) and breast (MDA-MB-435)" exact="cancer" post="cells [561]. Their mechanism of action has been reported"/>
  <result pre="a tumor suppressor gene product that may be involved in" exact="colon cancer" post="[516,561,562,563]. Some structurally related compounds were also found in"/>
  <result pre="tumor suppressor gene product that may be involved in colon" exact="cancer" post="[516,561,562,563]. Some structurally related compounds were also found in"/>
  <result pre="the sponge compounds neopetroformynes and are active against murine P388" exact="leukemia" post="cells with IC50 values of 0.09–0.45 μM [570]. Further"/>
  <result pre="four cell lines, i.e., murine P388 leukemia, A549 NSCLC, HT-29" exact="colon cancer," post="and SKMEL-28, at IC50 ~2 μM [571]. Hydroxy-dehydroisofulvinol (248)"/>
  <result pre="very selective, showing a ~4000-fold differential sensitivity between human Caco-2" exact="colon cancer" post="cells and HeLa cervix cancer cells [229]. Tambjamine C"/>
  <result pre="selective, showing a ~4000-fold differential sensitivity between human Caco-2 colon" exact="cancer" post="cells and HeLa cervix cancer cells [229]. Tambjamine C"/>
  <result pre="sensitivity between human Caco-2 colon cancer cells and HeLa cervix" exact="cancer" post="cells [229]. Tambjamine C (67), instead, is a good"/>
  <result pre="transmembrane anion transporter, similar to prodigiosins, which are relevant in" exact="cancer" post="cell biology and cancer cell migration, and they are"/>
  <result pre="to prodigiosins, which are relevant in cancer cell biology and" exact="cancer" post="cell migration, and they are expressed differently in diverse"/>
  <result pre="cancer cell migration, and they are expressed differently in diverse" exact="cancer" post="cells [581,582,583,584,585,586]. Dendronotida Within this group, several species have"/>
  <result pre="riisei, active at an IC50 of 0.03 µM to mouse" exact="leukemia" post="cells [587]. Dotofide (251) is found in Doto pinnatifida"/>
  <result pre="(251) shows a GI50 value of 18.1 µM for Hs683" exact="oligodendroglioma" post="(ATCC HTB-138), and of 28.8 µM for U373 glioblastoma"/>
  <result pre="values of GI50 around 6–9 μM against WHCO1 and WHCO6" exact="esophageal cancer" post="cell lines, inducing apoptosis via generation of reactive oxygen"/>
  <result pre="of GI50 around 6–9 μM against WHCO1 and WHCO6 esophageal" exact="cancer" post="cell lines, inducing apoptosis via generation of reactive oxygen"/>
  <result pre="IC50 values stand from ~0.4 to &amp;gt;100 μM in three" exact="cancer" post="cell lines, with no selectivity against mouse 3T3-L1 fibroblasts"/>
  <result pre="cardiomyocytes (IC50: ~0.1 and ~5 μM) [592,606]. Human HeLa cervix" exact="cancer" post="cells are very sensitive to the growth inhibitory effects"/>
  <result pre="the growth inhibitory effects of phidianidines (257), contrarily to Caco-2" exact="colon cancer" post="cells [606]. Phidianidines (257) are also selective and potent"/>
  <result pre="growth inhibitory effects of phidianidines (257), contrarily to Caco-2 colon" exact="cancer" post="cells [606]. Phidianidines (257) are also selective and potent"/>
  <result pre="compared to δ- and κ-opiod receptors), which is involved in" exact="cancer" post="progression [593,607]. Virtual screening allowed for the identification of"/>
  <result pre="for CXCR4, a chemokine receptor involved in several diseases, including" exact="cancer" post="progression, metastasis, and immunodeficiency disorders, and competing with natural"/>
  <result pre="migration at 50 μM in a rat cell line of" exact="pituitary adenoma" post="[609]. 3.1.2. Pleurobranchoidea Pleurobranchus albiguttatus and P. forskalii from"/>
  <result pre="at 50 μM in a rat cell line of pituitary" exact="adenoma" post="[609]. 3.1.2. Pleurobranchoidea Pleurobranchus albiguttatus and P. forskalii from"/>
  <result pre="an isoprene residue, which has been reported active against four" exact="cancer" post="cell lines (P388, A549, MEL20, and HT29) with IC50"/>
  <result pre="displays an IC50 value of 5.8 μM against murine P388" exact="leukemia" post="cells [387]. Unfortunately, the low sensitivity of this model"/>
  <result pre="chlorolissoclimide (258) and dichlorolissoclimide (259) were active against murine P388" exact="leukemia" post="cells resistant to adriamycin by blocking the translation elongation"/>
  <result pre="cyclodepsipeptide kulolide-1 (271), which displays potent antitumoral activity against L-1210" exact="leukemia" post="and P388 murine leukemia cell lines, with IC50 values"/>
  <result pre="displays potent antitumoral activity against L-1210 leukemia and P388 murine" exact="leukemia" post="cell lines, with IC50 values of 0.7 and 2.1"/>
  <result pre="effects with an IC50 of ~2 μM in murine P388" exact="leukemia" post="cells, while kulokekahilide-2 (276) presents a higher potency with"/>
  <result pre="(276) also displays activity against human SK-OV-3 ovarian and tMDA-MB-435" exact="breast cancer" post="cell lines, with IC50 values of 7.5 and 14.6"/>
  <result pre="also displays activity against human SK-OV-3 ovarian and tMDA-MB-435 breast" exact="cancer" post="cell lines, with IC50 values of 7.5 and 14.6"/>
  <result pre="an IC50 of 59.1 nM, acting selectively [627]. In other" exact="cancer" post="cell lines, namely, human A549 NSCLC, K562 chronic myelogenous"/>
  <result pre="namely, human A549 NSCLC, K562 chronic myelogenous leukemia, and MCF-7" exact="breast cancer," post="kulokekahilide-2 (276) shows IC50 values of ~0.2 nM [628]."/>
  <result pre="the same, with ~19 and ~4 nM for murine P388" exact="leukemia" post="and human HeLa cervix carcinoma cells, respectively [629]. Some"/>
  <result pre="fatty acids with cytotoxic activity against a range of human" exact="cancer" post="cells lines, including HT-29, MCF7, and A2058, were described"/>
  <result pre="A. dactylomela), which showed growth inhibitory activity against murine lymphocytic" exact="leukemia" post="P338 cells due to the presence of the brominated"/>
  <result pre="(277) showed an IC50 value of ~8 μM for P388" exact="leukemia" post="cells and human KB cancer cells [613,631]. A. dactylomela"/>
  <result pre="of ~8 μM for P388 leukemia cells and human KB" exact="cancer" post="cells [613,631]. A. dactylomela presents a wide variety of"/>
  <result pre="natural product, with IC50 values between 1–10 μM against ten" exact="cancer" post="cell lines in several studies [631,635,636]. Remarkably, elatol (278)"/>
  <result pre="HM02 (gastric carcinoma), HEP-G2 (liver carcinoma), and MCF-7 (breast carcinoma)" exact="cancer" post="cells with IC50 values of ~1 μM [631]. Some"/>
  <result pre="which displays potent IC50 values in the NCI assay (60" exact="cancer" post="cell lines panel), particularly an IC50 of ~0.4 μM"/>
  <result pre="panel), particularly an IC50 of ~0.4 μM in human SNB-19" exact="central nervous system cancer" post="and T-47D breast cancer cells [641]. Aplysqualenol A (287)"/>
  <result pre="IC50 of ~0.4 μM in human SNB-19 central nervous system" exact="cancer" post="and T-47D breast cancer cells [641]. Aplysqualenol A (287)"/>
  <result pre="μM in human SNB-19 central nervous system cancer and T-47D" exact="breast cancer" post="cells [641]. Aplysqualenol A (287) has been described to"/>
  <result pre="in human SNB-19 central nervous system cancer and T-47D breast" exact="cancer" post="cells [641]. Aplysqualenol A (287) has been described to"/>
  <result pre="a strong growth inhibitory in vitro activity against mouse P388" exact="leukemia" post="cells, and only moderate activity in solid tumors cell"/>
  <result pre="of ~0.02 and ~17 μM for P388 and A549 NSCLC" exact="cancer" post="cell lines, respectively [614,648,649]. Apparently, thyrsiferol (288) inhibits hypoxia-induced"/>
  <result pre="with an IC50 value of 2.5 μM for human HCT-116" exact="colorectal cancer" post="cells [606,650,651]. A. fasciata from Spain presents a degraded"/>
  <result pre="an IC50 value of 2.5 μM for human HCT-116 colorectal" exact="cancer" post="cells [606,650,651]. A. fasciata from Spain presents a degraded"/>
  <result pre="~8 μM against mouse P388 leukemia, human A549 NSCLC, HT-29" exact="colon cancer," post="and SKMEl-28 melanoma [397]. A. juliana contains two chlorophyll"/>
  <result pre="being tested in antitumor clinical trials [46,652,653,654,655,656]. For human HeLa-S3" exact="cancer" post="cells, IC50 values were 0.5 nM for aplyronine A"/>
  <result pre="a mean IC50 value of ~0.2 nM in the 60" exact="cancer" post="cell lines, but being selective against some cell lines"/>
  <result pre="selective against some cell lines and most active against MDR" exact="cancer" post="cell line NCI/ADR-RES, with an IC50 value of ~0.2"/>
  <result pre="nM, as well as for P388 murine leukemia, Lewis murine" exact="lung carcinoma," post="Erhlich murine carcinoma, colon 26 murine carcinoma, and B16"/>
  <result pre="cancers) [652]. Aplyronine A (191) also presents proapoptotic effects in" exact="cancer" post="cells [46]. Aplyronine A (191) was in fact suggested"/>
  <result pre="well-known tubulin inhibitors vincristine and vinblastine currently employed in some" exact="cancer" post="treatments [479,659,660]. Later, other studies suggested that aplyronine A"/>
  <result pre="show IC50 values of ~1 μM for human HeLa cervix" exact="cancer" post="cells, while neoaplaminone (296) is active at IC50 ~1"/>
  <result pre="and it shows IC50 values of 4–8 μM for several" exact="cancer" post="cells, with a mean IC50 value of ~30 μM"/>
  <result pre="sensitizer for tumor necrosis factor-related apoptosis, producing TRAIL-induced apoptosis in" exact="cancer" post="cells via the P38 MAPK/survivin pathway [682]. (-)-Aplysin (304)"/>
  <result pre="MAPK/survivin pathway [682]. (-)-Aplysin (304) is also effective against human" exact="glioma" post="cells by increasing miR-181 expression, sensitizing the cytotoxic effects"/>
  <result pre="the PI3K/Akt signaling, which is relevant in the survival of" exact="glioma" post="cells [683]. In Egypt, A. oculifera contains two halogenated"/>
  <result pre="IC50 values between 2 and 8 μM against human PC-3" exact="prostate cancer," post="A549 NSCLC, MCF-7 breast cancer, HepG2 liver cancer, and"/>
  <result pre="8 μM against human PC-3 prostate cancer, A549 NSCLC, MCF-7" exact="breast cancer," post="HepG2 liver cancer, and HCT116 colon cancer [684]. A."/>
  <result pre="human PC-3 prostate cancer, A549 NSCLC, MCF-7 breast cancer, HepG2" exact="liver cancer," post="and HCT116 colon cancer [684]. A. punctata from Spanish"/>
  <result pre="A549 NSCLC, MCF-7 breast cancer, HepG2 liver cancer, and HCT116" exact="colon cancer" post="[684]. A. punctata from Spanish coasts present atypical acetates"/>
  <result pre="NSCLC, MCF-7 breast cancer, HepG2 liver cancer, and HCT116 colon" exact="cancer" post="[684]. A. punctata from Spanish coasts present atypical acetates"/>
  <result pre="1.5 and 2.5 μM against P388, HT-29, A-549, and MEL-28" exact="cancer" post="cell lines [685]. Another sea hare, Dolabella auricularia, is"/>
  <result pre="IC50 values of ~0.2 μM against human HeLa S3 cervix" exact="cancer" post="cells, while auriside B (313) is less potent (IC50"/>
  <result pre="presents IC50 values of ~7 μM against human HeLa S3" exact="cancer" post="cells, and it is structurally similar to enshuol, a"/>
  <result pre="both values of ~2 μM against human HeLa S3 cervix" exact="cancer" post="cells, and synthesis studies are being carried out [692,693,701,702]."/>
  <result pre="cell line panel and was selective for renal, ovarian, and" exact="prostate cancer" post="cell lines. It was active in the in vivo"/>
  <result pre="line panel and was selective for renal, ovarian, and prostate" exact="cancer" post="cell lines. It was active in the in vivo"/>
  <result pre="1 (PHB1) in the mitochondria, activating the proteolytic processing of" exact="optic atrophy" post="1 (OPA1) and resulting in mitochondria-induced apoptosis [707]. Doliculide"/>
  <result pre="Its action mechanism consists of binding to actin and stopping" exact="cancer" post="cells at the G2/M phase of the cell cycle,"/>
  <result pre="and impairs the migratory potential of human MCF-7 and MDA-MB-231" exact="breast cancer" post="cells, while modifying senescence-related genes at non-toxic concentrations in"/>
  <result pre="impairs the migratory potential of human MCF-7 and MDA-MB-231 breast" exact="cancer" post="cells, while modifying senescence-related genes at non-toxic concentrations in"/>
  <result pre="while modifying senescence-related genes at non-toxic concentrations in p53 wild-type" exact="cancer" post="cells by up to 13% [713]. The most famous"/>
  <result pre="synthesized, showing an IC50 &amp;lt; 1 μM in P388 murine" exact="leukemia" post="cells [718,727]. Dolastatin 3 (192) was also found in"/>
  <result pre="78% life extension in vivo in the murine P388 lymphocytic" exact="leukemia" post="model, and a 52% life extension in murine colon"/>
  <result pre="FDA (Food and Drugs Administration) for the treatment of Hodgkin’s" exact="lymphoma" post="[43]. This ADC is composed of a highly toxic"/>
  <result pre="monoclonal antibody (mAb) directed to a particular epitope on the" exact="cancer" post="cell [726]. Dolastatin 10 (326) inhibits microtubule assembly, causing"/>
  <result pre="trials, local irritation at the injection site, and some mild" exact="peripheral neuropathy" post="[733,734]. Dolastatin 10 (326) exhibits cytotoxic effects against human"/>
  <result pre="local irritation at the injection site, and some mild peripheral" exact="neuropathy" post="[733,734]. Dolastatin 10 (326) exhibits cytotoxic effects against human"/>
  <result pre="Dolastatin 10 (326) exhibits cytotoxic effects against human lung and" exact="breast cancer" post="cell lines via both Bcl-2 phosphorylation and caspase-3 protein"/>
  <result pre="10 (326) exhibits cytotoxic effects against human lung and breast" exact="cancer" post="cell lines via both Bcl-2 phosphorylation and caspase-3 protein"/>
  <result pre="activation, and it modulates p53 oncoproteins in human diffuse large-cell" exact="lymphoma" post="[735,736]. Other studies describe dolastatin 10 (326) activity against"/>
  <result pre="leukemia, B16 melanoma, M5076 sarcoma, human LOX melanoma, and MX-1" exact="breast cancer" post="xenografts [736,737,738]. Dolastatin 10 (326) is not only an"/>
  <result pre="B16 melanoma, M5076 sarcoma, human LOX melanoma, and MX-1 breast" exact="cancer" post="xenografts [736,737,738]. Dolastatin 10 (326) is not only an"/>
  <result pre="several models, including murine P388 leukemia, colon 26 cancer, Lewis" exact="lung carcinoma," post="B16 melanoma, and M5076 sarcoma, as well as human"/>
  <result pre="B16 melanoma, and M5076 sarcoma, as well as human MX-1" exact="breast cancer" post="and LX-1 and SBC-3 SCLC xenografts [747,748]. Auristatin PE"/>
  <result pre="melanoma, and M5076 sarcoma, as well as human MX-1 breast" exact="cancer" post="and LX-1 and SBC-3 SCLC xenografts [747,748]. Auristatin PE"/>
  <result pre="for human SF-295 CNS cancer, ~0.1 μM for mouse neuro-2a" exact="neuroblastoma" post="and 1 μM for P388 leukemia cells [750,754,755]. Dolastatin"/>
  <result pre="μM for mouse neuro-2a neuroblastoma and 1 μM for P388" exact="leukemia" post="cells [750,754,755]. Dolastatin 11 (327) produces a massive rearrangement"/>
  <result pre="dolastatin 13 (329) and 14 (330) against the murine P388" exact="leukemia" post="cell line are reported to be 14 and 20"/>
  <result pre="tubulin, and it is a classical inducer of apoptosis in" exact="cancer" post="cells, acting as a conventional proapoptotic cytotoxic agent [762,763,764]."/>
  <result pre="is also a proapoptotic cytotoxic compound, tested against many different" exact="cancer" post="lines, but it did not go beyond phase II"/>
  <result pre="onchidin (121), which has submicromolar values of IC50 against four" exact="cancer" post="cell lines [773,774]. Dolastatin 18 (348) was found in"/>
  <result pre="and shows submicromolar values of IC50 against mouse P388 lymphocytic" exact="leukemia" post="and human NCI-H460 NSCLC cell lines [775]. D. auricularia"/>
  <result pre="in vitro growth inhibition for breast MCF-7 and colon KM20L2" exact="cancer" post="cells with IC50 values of ~1 μM [776]. Similarly,"/>
  <result pre="(335), and iso-dolastatin H (336), also display activity against some" exact="cancer" post="cell lines, such as human HeLa S3 cancer cells"/>
  <result pre="against some cancer cell lines, such as human HeLa S3" exact="cancer" post="cells [721,723,724]. Stylocheilus and Bursatella are also cyanobacterial feeders"/>
  <result pre="Makalikone (100) shows moderate activity against P388, A549, and HTB38" exact="cancer" post="cell lines, with IC50 values between 2.5 and 5"/>
  <result pre="cyanobacterial prey in Hawai’i, displays very potent toxicity against several" exact="cancer" post="cell lines, with IC50 values ~0.05 μg/mL [305]. Furthermore,"/>
  <result pre="O (102) shows IC50 values of 2 μg/mL against the" exact="cancer" post="cell lines P388, A549, and HT29 [123]. In Guam,"/>
  <result pre="B. leachii, possess in vitro growth inhibitory properties against several" exact="cancer" post="cell lines, with IC50 values between ~4 and ~8"/>
  <result pre="IC50 values between ~4 and ~8 μM against murine P388" exact="leukemia" post="and human A549 NSCLC, NCI-H187 (SCLC), HT-29 colon cancer,"/>
  <result pre="murine P388 leukemia and human A549 NSCLC, NCI-H187 (SCLC), HT-29" exact="colon cancer," post="HL60 leukemia, KB and BC breast cancer lines [307,786,787]."/>
  <result pre="NCI-H187 (SCLC), HT-29 colon cancer, HL60 leukemia, KB and BC" exact="breast cancer" post="lines [307,786,787]. Hectochlorin (351) and deacetylhectochlorin (352) show growth"/>
  <result pre="(SCLC), HT-29 colon cancer, HL60 leukemia, KB and BC breast" exact="cancer" post="lines [307,786,787]. Hectochlorin (351) and deacetylhectochlorin (352) show growth"/>
  <result pre="effects in vitro against human KB, NCI-H187 SCLCL, and BC" exact="breast cancer" post="cell lines, with deacetylhectochlorin (352) displaying a mean IC50"/>
  <result pre="in vitro against human KB, NCI-H187 SCLCL, and BC breast" exact="cancer" post="cell lines, with deacetylhectochlorin (352) displaying a mean IC50"/>
  <result pre="its diet of the green algae Caulerpa—is active against several" exact="cancer" post="cell lines at IC50 ~10 μM, while it has"/>
  <result pre="selective for normal (hamster fibroblasts, human keratinocytes, and melanocytes) and" exact="cancer" post="cells [790,791]. Caulerpenyne (155) induces tubulin aggregation, inhibiting the"/>
  <result pre="and tested in phase I trials in patients with hormone-refractory" exact="prostate cancer" post="[797,798]. Treating cancer cells with kahalalide F (194) resulted"/>
  <result pre="tested in phase I trials in patients with hormone-refractory prostate" exact="cancer" post="[797,798]. Treating cancer cells with kahalalide F (194) resulted"/>
  <result pre="I trials in patients with hormone-refractory prostate cancer [797,798]. Treating" exact="cancer" post="cells with kahalalide F (194) resulted in critical changes"/>
  <result pre="Kahalalide F (194) inhibits the PI3K–AKT signaling pathway in the" exact="breast cancer" post="cell lines SKBR3 and BT474 [800]. The IC50 values"/>
  <result pre="F (194) inhibits the PI3K–AKT signaling pathway in the breast" exact="cancer" post="cell lines SKBR3 and BT474 [800]. The IC50 values"/>
  <result pre="line panel were from 0.2 to 10 μM, with hormone-independent" exact="prostate cancer" post="cells being the most sensitive [267]. Kahalalide F (194)"/>
  <result pre="panel were from 0.2 to 10 μM, with hormone-independent prostate" exact="cancer" post="cells being the most sensitive [267]. Kahalalide F (194)"/>
  <result pre="Iso-kahalalide F (354) also entered phase II clinical trials for" exact="liver cancer," post="melanoma, and NSCLC patients, but was also ineffective [807]."/>
  <result pre="IC50 values between 0.4 and ~9 μM in a 23" exact="cancer" post="cell lines, including breast, colon, head and neck, lung,"/>
  <result pre="membrane level, interacting directly with glycosylceramides in the membrane of" exact="cancer" post="cells, while inducing necrosis-like cell death in the yeast"/>
  <result pre="active in vivo against human melanoma, liver, pancreas, breast, and" exact="prostate cancer" post="xenografts [816]. However, in clinical trials, elisidepsin (357) has"/>
  <result pre="in vivo against human melanoma, liver, pancreas, breast, and prostate" exact="cancer" post="xenografts [816]. However, in clinical trials, elisidepsin (357) has"/>
  <result pre="of ~6 μM when tested against human HCT-116 and HT29" exact="colon cancer" post="cells [819]. A secosterol (359) from T. costatus was"/>
  <result pre="~6 μM when tested against human HCT-116 and HT29 colon" exact="cancer" post="cells [819]. A secosterol (359) from T. costatus was"/>
  <result pre="with an IC50 value of ~3 μM against the WHCO1" exact="esophageal cancer" post="cell line [337]. Siphonaria species, S. capensis, S. concinna,"/>
  <result pre="an IC50 value of ~3 μM against the WHCO1 esophageal" exact="cancer" post="cell line [337]. Siphonaria species, S. capensis, S. concinna,"/>
  <result pre="(121) and onchidin B (360) are active against murine P388" exact="leukemia" post="and human KB oral cancer cells at IC50 values"/>
  <result pre="(360) are active against murine P388 leukemia and human KB" exact="oral cancer" post="cells at IC50 values of ~ 7 μM [358,359]."/>
  <result pre="are active against murine P388 leukemia and human KB oral" exact="cancer" post="cells at IC50 values of ~ 7 μM [358,359]."/>
  <result pre="with IC50 between 3 and 9 μM (A549 NSCLC, MCF-7" exact="breast cancer," post="PC-3 prostate cancer, Hs683 oligodendroglioma, U373 glioblastoma, and SKMEL-28"/>
  <result pre="3 and 9 μM (A549 NSCLC, MCF-7 breast cancer, PC-3" exact="prostate cancer," post="Hs683 oligodendroglioma, U373 glioblastoma, and SKMEL-28 melanoma), and being"/>
  <result pre="camptothecin [357]. This compound (362) seems to be active against" exact="cancer" post="cells that present resistance to proapoptotic stimuli [357]. Moreover,"/>
  <result pre="Fiji presents axisonitrile-3 (25), displaying strong growth inhibition against Mycobacterium" exact="tuberculosis" post="(MIC 2 μg/mL) [118,427]. Similarly, Phyllidia picta from Bali"/>
  <result pre="in the sponge Heteronema erecta, displays antibacterial activity towards M." exact="tuberculosis" post="H37Rv, with a MIC of 6.25 μg/mL [85,180,833]. Other"/>
  <result pre="are active against mycobacteria, with kahalalide A (377) inhibiting M." exact="tuberculosis" post="H37Rv by 83% at 12.5 μg/mL, and kahalalide F"/>
  <result pre="IX, producing heme accumulation, which results in toxicity to the" exact="malaria" post="parasite [849]. Pustulosaisonitrile-1 (378) from Phyllidiella pustulosa from Australia"/>
  <result pre="and digestive gland [22,166,380,381,535,536]. Spongiadiol (35) is active against the" exact="herpes simplex" post="virus, showing an IC50 of 0.25 μg/mL against herpes"/>
  <result pre="herpes simplex virus, showing an IC50 of 0.25 μg/mL against" exact="herpes simplex" post="virus type I [535,537]. Chromodoris hamiltoni presents a wide"/>
  <result pre="as reported above. Kahalalide F (194) presents antiviral properties against" exact="herpes simplex" post="virus II, while kahalalides A (377) and G (384)"/>
  <result pre="studied molecule as a potential treatment for many diseases, including" exact="cancer" post="and Alzheimer disease (AD), and it is in phase"/>
  <result pre="signaling pathway is crucial for treating many diseases, such as" exact="cancer" post="and heart failure, as well as neurodegenerative diseases [513]."/>
  <result pre="Lines HEL Human Erythroleukemia cells HeLa Henrietta_Lacks cell line from" exact="cervical cancer" post="cells HIF-1 Hypoxia Inducible Factor 1 HTCLs Human Tumor"/>
  <result pre="HEL Human Erythroleukemia cells HeLa Henrietta_Lacks cell line from cervical" exact="cancer" post="cells HIF-1 Hypoxia Inducible Factor 1 HTCLs Human Tumor"/>
  <result pre="The use of virtual screening for the discovery of small-molecule" exact="cancer" post="drugsMolecules201722103710.3390/molecules22071037 32.NewmanD.J.CraggG.M.Marine natural products and related compounds in clinical"/>
  <result pre="A source of novel anticancer drugsMar. Drugs20191749110.3390/md17090491 43.NewmanD.J.CraggG.M.Marine-sourced anti-cancer and" exact="cancer" post="pain control agents in clinical and late preclinical developmentMar."/>
  <result pre="the Antarctic nudibranch Austrodoris kerguelenensis and inhibition of Jak2/STAT5-dependent HEL" exact="leukemia" post="cellsTetrahedron2012689095910410.1016/j.tet.2012.08.045 68.CutignanoA.ZhangW.AvilaC.CiminoG.FontanaA.Intrapopulation variability in the terpene metabolism of the"/>
  <result pre="effect (on tumor cells) and in vitro antiviral activity against" exact="herpes simplex" post="virus of synthetic spongiane diterpenesJ. Nat. Prod.20026518919210.1021/np010206t11858754 385.KamelH.N.KimY.B.RimoldiJ.M.FronczekF.R.FerreiraD.SlatteryM.Scalarane sesterterpenoids:"/>
  <result pre="481.VinothkumarS.ParameswaranP.S.Recent advances in marine drug researchBiotechnol. Adv.2013311826184510.1016/j.biotechadv.2013.02.00623500952 482.NobiliS.LippiD.WitortE.DonniniM.BausiL.MiniE.CapaccioliS.Natural compounds for" exact="cancer" post="treatment and preventionPharmacol. Res.20095936537810.1016/j.phrs.2009.01.01719429468 483.BrayF.FerlayJ.SoerjomataramI.SiegelR.L.TorreL.A.JemalA.Global cancer statistics 2018: GLOBOCAN"/>
  <result pre="Adv.2013311826184510.1016/j.biotechadv.2013.02.00623500952 482.NobiliS.LippiD.WitortE.DonniniM.BausiL.MiniE.CapaccioliS.Natural compounds for cancer treatment and preventionPharmacol. Res.20095936537810.1016/j.phrs.2009.01.01719429468 483.BrayF.FerlayJ.SoerjomataramI.SiegelR.L.TorreL.A.JemalA.Global" exact="cancer" post="statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide"/>
  <result pre="induces ubiquitination and proteasome degradation of Bcl-2 in the human" exact="acute lymphoblastic leukemia" post="cell line, RehInt. J. Mol. Med.2000516523610.3892/ijmm.5.2.16510639596 504.ManzoE.CarboneM.MolloE.IraceC.Di PascaleA.LiY.CiavattaM.L.CiminoG.GuoY.-W.GavagninM.Structure and"/>
  <result pre="ubiquitination and proteasome degradation of Bcl-2 in the human acute" exact="lymphoblastic leukemia" post="cell line, RehInt. J. Mol. Med.2000516523610.3892/ijmm.5.2.16510639596 504.ManzoE.CarboneM.MolloE.IraceC.Di PascaleA.LiY.CiavattaM.L.CiminoG.GuoY.-W.GavagninM.Structure and"/>
  <result pre="and proteasome degradation of Bcl-2 in the human acute lymphoblastic" exact="leukemia" post="cell line, RehInt. J. Mol. Med.2000516523610.3892/ijmm.5.2.16510639596 504.ManzoE.CarboneM.MolloE.IraceC.Di PascaleA.LiY.CiavattaM.L.CiminoG.GuoY.-W.GavagninM.Structure and"/>
  <result pre="Nat. Prod.2017801339134610.1021/acs.jnatprod.6b0094128406636 506.ParikhM.RiessJ.LaraP.N.Jr.New and emerging developments in extensive-stage small cell" exact="lung cancer" post="therapeuticsCurr. Opin. Oncol.2016289710310.1097/CCO.000000000000026426844984 507.StuppR.HegiM.E.MasonW.P.Van Den BentM.J.TaphoornM.J.JanzerR.C.LudwinS.K.AllgeierA.FisherB.BelangerK.et al.Effects of radiotherapy"/>
  <result pre="Prod.2017801339134610.1021/acs.jnatprod.6b0094128406636 506.ParikhM.RiessJ.LaraP.N.Jr.New and emerging developments in extensive-stage small cell lung" exact="cancer" post="therapeuticsCurr. Opin. Oncol.2016289710310.1097/CCO.000000000000026426844984 507.StuppR.HegiM.E.MasonW.P.Van Den BentM.J.TaphoornM.J.JanzerR.C.LudwinS.K.AllgeierA.FisherB.BelangerK.et al.Effects of radiotherapy"/>
  <result pre="anticancer effect in a peritoneal dissemination model of human gastric" exact="cancer" post="in miceAnticancer Res.2009292091209719528469 521.ProtaA.E.BargstenK.NorthcoteP.T.MarshM.AltmannK.H.MillerJ.H.DıazJ.F.SteinmetzM.O.Structural basis of microtubule stabilization by"/>
  <result pre="trisoxazole macrolide from the marine sponge Chondrosia corticata, on human" exact="prostate cancer" post="cells via modulation of epithelial-to-mesenchymal transitionMar. Drugs2013112472248510.3390/md1107247223860239 552.BaeS.Y.KimG.D.JeonJ.E.ShinJ.LeeS.K.Anti-proliferative effect"/>
  <result pre="macrolide from the marine sponge Chondrosia corticata, on human prostate" exact="cancer" post="cells via modulation of epithelial-to-mesenchymal transitionMar. Drugs2013112472248510.3390/md1107247223860239 552.BaeS.Y.KimG.D.JeonJ.E.ShinJ.LeeS.K.Anti-proliferative effect"/>
  <result pre="Chondrosia corticata, is associated with G2/M cell cycle arrest and" exact="suppression" post="of mTOR signaling in human lung cancer cellsToxicol. In"/>
  <result pre="cell cycle arrest and suppression of mTOR signaling in human" exact="lung cancer" post="cellsToxicol. In Vitro20132769469910.1016/j.tiv.2012.11.00123147639 553.FontanaA.CavaliereP.WahidullaS.NaikC.G.CiminoG.A new antitumor isoquinoline alkaloid from"/>
  <result pre="cycle arrest and suppression of mTOR signaling in human lung" exact="cancer" post="cellsToxicol. In Vitro20132769469910.1016/j.tiv.2012.11.00123147639 553.FontanaA.CavaliereP.WahidullaS.NaikC.G.CiminoG.A new antitumor isoquinoline alkaloid from"/>
  <result pre="renieramycin M-jorunnamycin a analoguesBioorg. Med. Chem.2009174548455810.1016/j.bmc.2009.05.00919457672 562.McPhersonJ.R.OngC.K.NgC.C.Y.RajasegaranV.HengH.L.YuW.S.S.TanB.K.T.MadhukumarP.TeoM.C.C.NgeowJ.et al.Whole-exome sequencing of" exact="breast cancer," post="malignant peripheral nerve sheath tumor and neurofibroma from a"/>
  <result pre="a analoguesBioorg. Med. Chem.2009174548455810.1016/j.bmc.2009.05.00919457672 562.McPhersonJ.R.OngC.K.NgC.C.Y.RajasegaranV.HengH.L.YuW.S.S.TanB.K.T.MadhukumarP.TeoM.C.C.NgeowJ.et al.Whole-exome sequencing of breast cancer," exact="malignant peripheral nerve sheath tumor" post="and neurofibroma from a patient with neurofibromatosis type 1Cancer"/>
  <result pre="sequencing of breast cancer, malignant peripheral nerve sheath tumor and" exact="neurofibroma" post="from a patient with neurofibromatosis type 1Cancer Med.201541871187810.1002/cam4.55126432421 563.StormE.E.DurinckS.e"/>
  <result pre="peripheral nerve sheath tumor and neurofibroma from a patient with" exact="neurofibromatosis" post="type 1Cancer Med.201541871187810.1002/cam4.55126432421 563.StormE.E.DurinckS.e MeloF.D.S.TremayneJ.KljavinN.TanC.YeX.ChiuC.PhamT.HongoJ.A.et al.Targeting PTPRK-RSPO3 colon tumours"/>
  <result pre="expression of organic anion-transporting polypeptides: Transporters as novel targets for" exact="cancer" post="therapyJ. Drug Deliv.2013201311210.1155/2013/863539 585.AbuAliG.GrimmS.Isolation and characterization of the anticancer"/>
  <result pre="(ORCTL3)Anticancer GenesSpringerLondon, UK2014213227 586.LiuT.LiQ.Organic anion-transporting polypeptides: A novel approach for" exact="cancer" post="therapyJ. Drug. Target.201422142210.3109/1061186X.2013.83276723987090 587.BakerB.ScheuerP.The punaglandins: 10-chloroprostanoids from the octocoral"/>
  <result pre="Davies-Coleman, M.T.; Hendricks, D.T. Reactive oxygen species mediated apoptosis of" exact="esophageal cancer" post="cells induced by marine triprenyl toluquinones and toluhydroquinonesMol. Cancer"/>
  <result pre="M.T.; Hendricks, D.T. Reactive oxygen species mediated apoptosis of esophageal" exact="cancer" post="cells induced by marine triprenyl toluquinones and toluhydroquinonesMol. Cancer"/>
  <result pre="602.LukinA.KarapetianR.IvanenkovY.KrasavinM.Privileged 1,2,4-oxadiazoles in anticancer drug design: Novel 5-aryloxymethyl-1,2,4-oxadiazole leads for" exact="prostate cancer" post="therapyLett. Drug Des. Discov.20161319820410.2174/1570180812999150812164251 603.Pitasse-SantosP.Sueth-SantiagoV.LimaM.E.F.1,2,4- and 1,3,4-oxadiazoles as scaffolds"/>
  <result pre="1,2,4-oxadiazoles in anticancer drug design: Novel 5-aryloxymethyl-1,2,4-oxadiazole leads for prostate" exact="cancer" post="therapyLett. Drug Des. Discov.20161319820410.2174/1570180812999150812164251 603.Pitasse-SantosP.Sueth-SantiagoV.LimaM.E.F.1,2,4- and 1,3,4-oxadiazoles as scaffolds"/>
  <result pre="Org. Chem.1990554426443110.1021/jo00301a040 607.SingletonP.A.MossJ.KarpD.D.AtkinsJ.T.JankuF.The mu opioid receptor: A new target for" exact="cancer" post="therapy?Cancer20151212681268810.1002/cncr.2946026043235 608.VitaleR.M.GattiM.CarboneM.BarbieriF.FelicitàV.GavagninM.FlorioT.AmodeoP.Minimalist hybrid ligand/receptor-based pharmacophore model for CXCR4 applied"/>
  <result pre="Quick excursus from basic molecular mechanisms to some implications in" exact="cancer" post="chemotherapyEur. Rev. Med. Pharmacol. Sci.200913132119364082 645.WongD.M.LiL.JuradoS.KingA.BamfordR.WallM.WaliaM.K.KellyG.L.WalkleyC.R.TarlintonD.M.et al.The transcription factor"/>
  <result pre="from the red alga Laurencia okamuraeNat. Prod. Sci.20028103107 682.LiuJ.MaL.WuN.LiuG.ZhengL.LinX.Aplysin sensitizes" exact="cancer" post="cells to TRAIL by suppressing P38 MAPK/survivin pathwayMar. Drugs2014125072508810.3390/md1209507225257790"/>
  <result pre="by suppressing P38 MAPK/survivin pathwayMar. Drugs2014125072508810.3390/md1209507225257790 683.GongA.J.GongL.L.YaoW.C.GeN.LuL.X.LiangH.Aplysin induces apoptosis in" exact="glioma" post="cells through HSP90/AKT pathwayExp. Biol. Med.201524063964410.1177/1535370214555664 684.HegazyM.E.F.MoustfaA.Y.MohamedA.E.H.H.AlhammadyM.A.ElbehairiS.E.I.OhtaS.ParéP.W.New cytotoxic halogenated"/>
  <result pre="Japanese sea hare Dolabella auriculariaTetrahedron Lett.1996376771677410.1016/S0040-4039(96)01464-5 704.HanB.GrossH.GoegerD.E.MooberryS.L.GerwickW.H.Aurilides B and C," exact="cancer" post="cell toxins from a Papua New Guinea collection of"/>
  <result pre="10 analogInt. J. Cancer200310451252110.1002/ijc.1098212584751 736.KalemkerianG.P.OuX.AdilM.R.RosatiR.KhoulaniM.M.MadanS.K.PettitG.R.Activity of dolastatin 10 against small-cell" exact="lung cancer" post="in vitro and in vivo: Induction of apoptosis and"/>
  <result pre="analogInt. J. Cancer200310451252110.1002/ijc.1098212584751 736.KalemkerianG.P.OuX.AdilM.R.RosatiR.KhoulaniM.M.MadanS.K.PettitG.R.Activity of dolastatin 10 against small-cell lung" exact="cancer" post="in vitro and in vivo: Induction of apoptosis and"/>
  <result pre="plasma by radioimmunoassayCancer Chemother. Pharmacol.19963822523210.1007/s0028000504758646796 739.WatanabeJ.NatsumeT.FujioN.MiyasakaK.KobayashiM.Induction of apoptosis in human" exact="cancer" post="cells by TZT-1027, an antimicrotubule agentApoptosis2000534535310.1023/A:100968760933011227216 740.Verdier-PinardP.KeplerJ.A.PettitG.R.HamelE.Sustained intracellular retention"/>
  <result pre="Pharmacol.20005718018710617693 741.DoroninaS.O.TokiB.E.TorgovM.Y.MendelsohnB.A.CervenyC.G.ChaceD.F.DeBlancR.L.GearingR.P.BoveeT.D.SiegallC.B.et al.Development of potent monoclonal antibody auristatin conjugates for" exact="cancer" post="therapyNature Biotech.20032177878410.1038/nbt83212778055 742.SteinmetzM.O.ProtaA.E.Microtubule-targeting agents: Strategies to hijack the cytoskeletonTrends"/>
  <result pre="763.AliM.A.RosatiR.PettitG.KalemkerianG.P.Dolastatin 15 induces apoptosis and BCL-2 phosphorylation in small cell" exact="lung cancer" post="cell linesAnticancer Res.199818102110269615758 764.SatoM.SagawaM.NakazatoT.IkedaY.KizakiM.A natural peptide, dolastatin 15, induces"/>
  <result pre="15 induces apoptosis and BCL-2 phosphorylation in small cell lung" exact="cancer" post="cell linesAnticancer Res.199818102110269615758 764.SatoM.SagawaM.NakazatoT.IkedaY.KizakiM.A natural peptide, dolastatin 15, induces"/>
  <result pre="15, induces G2/M cell cycle arrest and apoptosis of human" exact="multiple myeloma" post="cellsInt. J. Oncol.2007301453145910.3892/ijo.30.6.145317487366 765.BeckwithM.UrbaW.J.LongoD.L.Growth inhibition of human lymphoma cell"/>
  <result pre="human multiple myeloma cellsInt. J. Oncol.2007301453145910.3892/ijo.30.6.145317487366 765.BeckwithM.UrbaW.J.LongoD.L.Growth inhibition of human" exact="lymphoma" post="cell lines by the marine products, dolastatins 10 and"/>
  <result pre="from GuamJ. Nat. Prod.20117491792710.1021/np200076t21446699 770.PettitG.R.XuJ.P.HoganF.WilliamsM.D.DoubekD.L.SchmidtJ.M.CernyR.L.BoydM.R.Isolation and structure of the human" exact="cancer" post="cell growth inhibitory cyclodepsipeptide dolastatin 16J. Nat. Prod.19976075275410.1021/np97002309287413 771.NogleL.M.GerwickW.H.Isolation"/>
  <result pre="a new marine-derived compound, induces oncosis in human prostate and" exact="breast cancer" post="cellsMol. Cancer Ther.2003286387214555705 800.JanmaatM.L.RodriguezJ.A.JimenoJ.KruytF.A.E.GiacconeG.Kahalalide F induces necrosis-like cell death"/>
  <result pre="new marine-derived compound, induces oncosis in human prostate and breast" exact="cancer" post="cellsMol. Cancer Ther.2003286387214555705 800.JanmaatM.L.RodriguezJ.A.JimenoJ.KruytF.A.E.GiacconeG.Kahalalide F induces necrosis-like cell death"/>
  <result pre="linesEur. J. Cancer2005411637164410.1016/j.ejca.2005.04.01515953713 804.Miguel-LilloB.ValenzuelaB.Peris-RiberaJ.E.Soto-MatosA.Pérez-RuixoJ.J.Population pharmacokinetics of kahalalide F in advanced" exact="cancer" post="patientsCancer Chemother. Pharmacol.20157636537410.1007/s00280-015-2800-126093949 805.Martín-AlgarraS.EspinosaE.RubióJ.LópezJ.J.L.ManzanoJ.L.CarriónL.A.PlazaolaA.TanovicA.Paz-AresL.Phase II study of weekly Kahalalide"/>
  <result pre="al.Phase Ib/II study of elisidepsin in metastatic or advanced gastroesophageal" exact="cancer" post="(IMAGE trial)Cancer Chemother. Pharmacol.20167781982710.1007/s00280-016-2991-026964995 818.CiavattaM.L.VillaniG.TrivelloneE.CiminoG.Two new labdane aldehydes from"/>
  <result pre="HTCLs [491] Polycera atra Bryostatins (203) Cytotoxic to P388 lymphocytic" exact="leukemia" post="and Alzheimer’s disease cells [424,486,487] Actinocyclus papillatus (–)-Actisonitrile (204),"/>
  <result pre="A–N (16, 206), isodrimeninol (207), 11-epivaldiviolide (208) Cytotoxic to murine" exact="leukemia" post="P388 cell lines [86,509] Phyllidiella coelestis 1-Formamido-10(1→2)-abeopupukeanane (209), 2-formamidopupukeanane"/>
  <result pre="1-Formamido-10(1→2)-abeopupukeanane (209), 2-formamidopupukeanane (210) Cytotoxic to HeLa, MCF-7, KB, HT-29" exact="cancer" post="cell lines [111] Phyllidiella pustulosa Axinisothiocyanate K (211), isothiocyanate"/>
  <result pre="B Cytotoxic in vitro to KB cells and mouse L1210" exact="leukemia" post="cells [438,511,512] Cadlina luteomarginata Ansellone A (216) Activation of"/>
  <result pre="lochi Mycothiazole (129) Inhibition of the hypoxia-inducible factor-1 (HIF-1), and" exact="suppression" post="of the mitochondrial respiration at complex I [378,379,825,826] Chromodoris"/>
  <result pre="[142,523,524] Chromodoris inornata Inorolides A–C (217) Cytotoxic to murine L1210" exact="leukemia" post="and human epidermoid carcinoma KB cell lines [156,531] Chromodoris"/>
  <result pre="Dorisenones A–D (229), 11β-hydroxyspongi-12-en-16-one (230), spongian-16-one (221) Cytotoxic to murine" exact="lymphoma" post="L1210 and KB cells [154] Doriprismatica (Glossodoris) atromarginata Spongiadiol"/>
  <result pre="12-deacetoxy-12-oxodeoxoscalarin (136), heteronemin (233), mooloolabene D (234) Cytotoxic to MCF-7" exact="breast cancer" post="cells [180,182,381,828] Felimida (Glossodoris) dalli, Doriprismatica (Glossodoris) sedna, Glossodoris"/>
  <result pre="(136), heteronemin (233), mooloolabene D (234) Cytotoxic to MCF-7 breast" exact="cancer" post="cells [180,182,381,828] Felimida (Glossodoris) dalli, Doriprismatica (Glossodoris) sedna, Glossodoris"/>
  <result pre="(63), 33-methylhalichondramide (242), halichondramide (244), Hurghadin Cytotoxic to murine L1210" exact="leukemia" post="cells, cytotoxic to several HTCLs, and cytotoxic to human"/>
  <result pre="cells, cytotoxic to several HTCLs, and cytotoxic to human MCF-7" exact="breast cancer" post="cells [545] Jorunna funebris Jorumycin (189), jorunnamycins A–C (245),"/>
  <result pre="cytotoxic to several HTCLs, and cytotoxic to human MCF-7 breast" exact="cancer" post="cells [545] Jorunna funebris Jorumycin (189), jorunnamycins A–C (245),"/>
  <result pre="Jorumycin (189), jorunnamycins A–C (245), renieramycin M (246) Cytotoxic to" exact="cancer" post="cell lines P388, A549, HT29, and MEL28, and cytotoxic"/>
  <result pre="MEL28, and cytotoxic to human colon (HCT-116) and breast (MDA-MB-435)" exact="cancer" post="cells [560] Jorunna funebris Fennebricins A and B, N-formyl-1,2-dihydrorenierol"/>
  <result pre="atromaculata Petroformynes (247), hydroxyl-dehydroisofulvinol (248), fulvinol Cytotoxic to murine P388" exact="leukemia" post="cells, A549 NSCLC, HT-29 colon cancer and SKMEL-28 melanoma"/>
  <result pre="fulvinol Cytotoxic to murine P388 leukemia cells, A549 NSCLC, HT-29" exact="colon cancer" post="and SKMEL-28 melanoma cells [567,568] Halgerda aurantiomaculata Zooanemonin (367)"/>
  <result pre="Cytotoxic to murine P388 leukemia cells, A549 NSCLC, HT-29 colon" exact="cancer" post="and SKMEL-28 melanoma cells [567,568] Halgerda aurantiomaculata Zooanemonin (367)"/>
  <result pre="(249), tetrapyrrole (72) Cytotoxic to several tumor cell lines (Caco-2" exact="colon cancer" post="cells, HeLa cervix cancer cells) Tritonia sp. Punaglandins (250)"/>
  <result pre="tetrapyrrole (72) Cytotoxic to several tumor cell lines (Caco-2 colon" exact="cancer" post="cells, HeLa cervix cancer cells) Tritonia sp. Punaglandins (250)"/>
  <result pre="several tumor cell lines (Caco-2 colon cancer cells, HeLa cervix" exact="cancer" post="cells) Tritonia sp. Punaglandins (250) Cytotoxic [587] Doto pinnatifida"/>
  <result pre="[22] Leminda millecra Prenylated hydroquinone (252) Cytotoxic to WHCO1, WHCO6" exact="esophageal cancer" post="cell lines [588,589,590] Hermissenda crassicornis L-6-bromohypaphorine (253) Cytotoxic to"/>
  <result pre="Leminda millecra Prenylated hydroquinone (252) Cytotoxic to WHCO1, WHCO6 esophageal" exact="cancer" post="cell lines [588,589,590] Hermissenda crassicornis L-6-bromohypaphorine (253) Cytotoxic to"/>
  <result pre="Phyllodesmium briareum Brianthein W (254), excavatolide C (255) Cytotoxic to" exact="cancer" post="cell line P-388 [248] Phyllodesmium magnum 11-episinulariolide acetate (256)"/>
  <result pre="line P-388 [248] Phyllodesmium magnum 11-episinulariolide acetate (256) Cytotoxic to" exact="cancer" post="cell line P-388 [248] Phyllodesmium longicirrum Trocheliophorol (84) Cytotoxic"/>
  <result pre="(276) Cytotoxic to L-1210, P388 leukemia, human SK-OV-3 ovarian, tMDA-MB-435" exact="breast cancer," post="human A549 NSCLC, K562 chronic myelogenous leukemia, HeLa cervix"/>
  <result pre="NSCLC, K562 chronic myelogenous leukemia, HeLa cervix carcinoma, and MCF-7" exact="breast cancer" post="cell lines [277,626,627,628] Scaphander lignarius ARA, EPA, HTA (fatty"/>
  <result pre="K562 chronic myelogenous leukemia, HeLa cervix carcinoma, and MCF-7 breast" exact="cancer" post="cell lines [277,626,627,628] Scaphander lignarius ARA, EPA, HTA (fatty"/>
  <result pre="ARA, EPA, HTA (fatty acids) Cytotoxic to a set of" exact="cancer" post="and normal cell lines [630] Anaspidea (11) Aplysia angasi,"/>
  <result pre="(279), iso-obtusol (280), linear halogenated monoterpene (281) Cytotoxic to ten" exact="cancer" post="cell lines, B16F10 melanoma, HM02 gastric carcinoma, HEP-G2 liver"/>
  <result pre="HM02 gastric carcinoma, HEP-G2 liver carcinoma, and MCF-7 breast carcinoma" exact="cancer" post="cells [631,633,632,633] A. dactylomela Parguerol (282), parguerol-16-acetate (283), iso-parguerol"/>
  <result pre="(283), iso-parguerol (284), iso-parguerol-16-acetate (285), deoxyparguerol (286) Cytotoxic to P388" exact="leukemia" post="and Ehrlich ascite carcinoma cells [611,636,640] A. dactylomela Aplysqualenol"/>
  <result pre="cells [611,636,640] A. dactylomela Aplysqualenol A (287) Cytotoxic to 60" exact="cancer" post="cell lines [641,642] A. dactylomela Thyrsiferol (288) Cytotoxic to"/>
  <result pre="cell lines [641,642] A. dactylomela Thyrsiferol (288) Cytotoxic to P388" exact="leukemia" post="and T47D human breast tumor cells, and suppression of"/>
  <result pre="to P388 leukemia and T47D human breast tumor cells, and" exact="suppression" post="of hypoxic induction of HIF-1 target genes [647,648,649] Aplysia"/>
  <result pre="[647,648,649] Aplysia depilans Endoperoxide sterol (289) Cytotoxic to human HCT-116" exact="colorectal cancer" post="cells [650,651] Aplysia fasciata 3-epi-aplykurodinone B (145) Cytotoxic to"/>
  <result pre="Aplysia depilans Endoperoxide sterol (289) Cytotoxic to human HCT-116 colorectal" exact="cancer" post="cells [650,651] Aplysia fasciata 3-epi-aplykurodinone B (145) Cytotoxic to"/>
  <result pre="(145) Cytotoxic to mouse P388 leukemia, human A549 NSCLC, HT-29" exact="colon cancer," post="and SKMEl-28 melanoma [397] Aplysia juliana Pyropheophorbides a and"/>
  <result pre="(303), aplysianin A Induction of growth inhibitory effects in various" exact="cancer" post="cell lines [668,669,670,671,672,673,674] A. kurodai (-)-Aplysin (304), aplysinol (305),"/>
  <result pre="(305), aplykurodins A (306) and B (146) Cytotoxic to various" exact="cancer" post="cell lines, human A549 NSCLC, and human glioma cells"/>
  <result pre="to various cancer cell lines, human A549 NSCLC, and human" exact="glioma" post="cells [680,682,683] Aplysia oculifera Oculiferane (308), epi-obtusane (309) Cytotoxic"/>
  <result pre="PC-3 prostate, A549 NSCLC, MCF-7 breast, HepG2 liver, and HCT116" exact="colon cancer" post="cell lines [684] Aplysia punctata Halogenated monoterpenes (310–312) Cytotoxic"/>
  <result pre="prostate, A549 NSCLC, MCF-7 breast, HepG2 liver, and HCT116 colon" exact="cancer" post="cell lines [684] Aplysia punctata Halogenated monoterpenes (310–312) Cytotoxic"/>
  <result pre="C (322) and D (323) Cytotoxic to human HeLa S3" exact="cancer" post="cells [687,696,701,702] D. auricularia Doliculide (325) Cytotoxic to human"/>
  <result pre="Doliculide (325) Cytotoxic to human HeLa S3, MCF-7, and MDA-MB-231" exact="breast cancer" post="cells [708] D. auricularia Dolastatins 3 (192), 10 (326),"/>
  <result pre="(325) Cytotoxic to human HeLa S3, MCF-7, and MDA-MB-231 breast" exact="cancer" post="cells [708] D. auricularia Dolastatins 3 (192), 10 (326),"/>
  <result pre="PE (344), tasidotin (345) Cytotoxic to renal, ovarian, prostate, hepatobiliary," exact="pancreatic cancer" post="cell lines, P388 murine leukemia, colon 26 cancer, Lewis"/>
  <result pre="(344), tasidotin (345) Cytotoxic to renal, ovarian, prostate, hepatobiliary, pancreatic" exact="cancer" post="cell lines, P388 murine leukemia, colon 26 cancer, Lewis"/>
  <result pre="cancer cell lines, P388 murine leukemia, colon 26 cancer, Lewis" exact="lung carcinoma," post="B16 melanoma, M5076 sarcoma, human MX-1 breast cancer, LX-1,"/>
  <result pre="cancer, Lewis lung carcinoma, B16 melanoma, M5076 sarcoma, human MX-1" exact="breast cancer," post="LX-1, MCF-7, colon KM20L2 cancer, and SBC-3 SCLC cell"/>
  <result pre="and P (103) Cytotoxic to P388, A549, HT29, and HTB38" exact="cancer" post="cell lines, and toxic to mice [302,304,305,307,777,778,779] Bursatella leachii"/>
  <result pre="to murine P388 leukemia, human A549, NSCLC, NCI-H187 (SCLC), HT-29" exact="colon cancer," post="HL60 leukemia, KB, and BC breast cancer [783,784,785,786,787] Sacoglossa"/>
  <result pre="NCI-H187 (SCLC), HT-29 colon cancer, HL60 leukemia, KB, and BC" exact="breast cancer" post="[783,784,785,786,787] Sacoglossa (3) Elysia subornata Caulerpenyne (155) Cytotoxic to"/>
  <result pre="(SCLC), HT-29 colon cancer, HL60 leukemia, KB, and BC breast" exact="cancer" post="[783,784,785,786,787] Sacoglossa (3) Elysia subornata Caulerpenyne (155) Cytotoxic to"/>
  <result pre="cancer [783,784,785,786,787] Sacoglossa (3) Elysia subornata Caulerpenyne (155) Cytotoxic to" exact="neuroblastoma" post="SK-N-SH cell line [316,411,788,789,790] Elysia rufescens Kahalide F (194),"/>
  <result pre="F (354) Cytotoxic to A549 and Hs683 cell lines, and" exact="breast cancer" post="cell lines SKBR3 and BT474 [331,797,800] Elysia ornata Kahalides"/>
  <result pre="(354) Cytotoxic to A549 and Hs683 cell lines, and breast" exact="cancer" post="cell lines SKBR3 and BT474 [331,797,800] Elysia ornata Kahalides"/>
  <result pre="peruvianus Hydroxylated sterol (358) Cytotoxic to human HCT-116 and HT29" exact="colon cancer" post="cell lines [819] Trimusculus costatus Secosterol (359) Cytotoxic to"/>
  <result pre="Hydroxylated sterol (358) Cytotoxic to human HCT-116 and HT29 colon" exact="cancer" post="cell lines [819] Trimusculus costatus Secosterol (359) Cytotoxic to"/>
  <result pre="cell lines [819] Trimusculus costatus Secosterol (359) Cytotoxic to WHCO1" exact="esophageal cancer" post="cell line [337] Siphonaria capensis, S. concinna, S. cristatus,"/>
  <result pre="lines [819] Trimusculus costatus Secosterol (359) Cytotoxic to WHCO1 esophageal" exact="cancer" post="cell line [337] Siphonaria capensis, S. concinna, S. cristatus,"/>
  <result pre="(361), ilikonapyrones (362,363), onchidionol Cytotoxic to murine P388 and KB" exact="oral cancer" post="cells, and regulation of some genes related to tumor"/>
  <result pre="ilikonapyrones (362,363), onchidionol Cytotoxic to murine P388 and KB oral" exact="cancer" post="cells, and regulation of some genes related to tumor"/>
  <result pre="Nudibranchia (21) Phyllidiella pustulosa Axisonitrile-3 (25) Antimycobacterial activity against Mycobacterium" exact="tuberculosis" post="[427] P. pustulosa, P. coelestis Xidaoisocyanate A (24) Antibiotic"/>
  <result pre="Doriorismatica (Glossodoris) atromarginata Scalaranes, heteronemin (233) Antimycobacterial activity against M." exact="tuberculosis" post="H37Rv [833] Glossodoris hikuerensis, G. vespa, G. cincta Heteronemin"/>
  <result pre="and F (194), iso-kahalalide F (354) Antimycobacterial activity against Mycobacterium" exact="tuberculosis" post="and M. intracellulare [794] Elysia ornata, E. grandifolia Kahalalide"/>
  <result pre="ornata, E. grandifolia Kahalalide F (194) Antimycobacterial activity against M." exact="tuberculosis" post="and M. intracellulare [331,411,797] Cyerce nigricans Chlorodesmin (114) Antibacterial"/>
  <result pre="Chromodoris mandapamensis, Glossodoris cincta Spongiadiol (35), epi-spongiadiol (232) Activity against" exact="herpes simplex" post="virus, type 1 (HSV-1) and P388 murine leukemia cells"/>
  <result pre="against herpes simplex virus, type 1 (HSV-1) and P388 murine" exact="leukemia" post="cells [166,535] Chromodoris hamiltoni Latrunculins A (38) and B"/>
  <result pre="E. ornata Kahalalide F (194), iso-kahalalide F (354) Activity against" exact="herpes simplex" post="virus II [331,794,795,797,853] marinedrugs-18-00657-t014_Table 14Table 14 Anti-inflammatory compounds in"/>
 </snippets>
</snippetsTree>
